Inflammation and atherosclerosis Group IIa and Group V sPLA2 are not redundant

被引：13

作者：

de Beer, Frederick C.

Webb, Nancy R.

机构：

[1] Univ Kentucky, Med Ctr, Dept Internal Med, Lexington, KY 40536 USA

[2] Univ Kentucky, Cardiovasc Res Ctr, Lexington, KY USA

来源：

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY | 2006年 / 26卷 / 07期

关键词：

D O I：

10.1161/01.ATV.0000227561.89488.9a

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1421 / 1422

页数：2

共 13 条

[1] Sera of patients suffering from inflammatory diseases contain group IIA but not group V phospholipase A2 [J].

Aarsman, AJ ;

Neys, FW ;

van der Helm, HA ;

Kuypers, FA ;

van den Bosch, H .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE, 2000, 1502 (02) :257-263

[2] Serum levels of type II secretory phospholipase A2 and the risk of future coronary artery disease in apparently healthy men and women - The EPIC-Norfolk Prospective Population study [J].

Boekholdt, SM ;

Keller, TT ;

Wareham, NJ ;

Luben, R ;

Bingham, SA ;

Day, NE ;

Sandhu, MS ;

Jukema, JW ;

Kastelein, JJP ;

Hack, CE ;

Khaw, KT .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2005, 25 (04) :839-846

[3] Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans [J].

Boyanovsky, BB ;

van der Westhuyzen, DR ;

Webb, NR .

JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (38) :32746-32752

[4]

de Beer FC, 2000, J LIPID RES, V41, P1849

[5] Role of group IIa and group V secretory phospholipases A2 in the metabolism of lipoproteins.: Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin [J].

Gesquiere, L ;

Cho, WH ;

Subbaiah, PV .

BIOCHEMISTRY, 2002, 41 (15) :4911-4920

[6] Group V and X secretory phospholipase A2s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions [J].

Ishimoto, Y ;

Yamada, K ;

Yamamoto, S ;

Ono, T ;

Notoya, M ;

Hanasaki, K .

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 2003, 1642 (03) :129-138

[7] Role of group II secretory phospholipase A2 in atherosclerosis -: 1.: Increased atherogenesis and altered lipoproteins in transgenic mice expressing group IIa phospholipase A2 [J].

Ivandic, B ;

Castellani, LW ;

Wang, XP ;

Qiao, JH ;

Mehrabian, M ;

Navab, M ;

Fogelman, AM ;

Grass, DS ;

Swanson, ME ;

de Beer, MC ;

de Beer, F ;

Lusis, AJ .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (05) :1284-1290

[8] Circulating levels of secretory type II phospholipase A2 predict coronary events in patients with coronary artery disease [J].

Kugiyama, K ;

Ota, Y ;

Takazoe, K ;

Moriyama, Y ;

Kawano, H ;

Miyao, Y ;

Sakamoto, T ;

Soejima, H ;

Ogawa, H ;

Doi, H ;

Sugiyama, S ;

Yasue, H .

CIRCULATION, 1999, 100 (12) :1280-1284

[9] Role of lipoprotein-associated phospholipase A2 in atherosclerosis and its potential as a therapeutic target [J].

Macphee, CH ;

Nelson, J ;

Zalewski, A .

CURRENT OPINION IN PHARMACOLOGY, 2006, 6 (02) :154-161

[10] Secretory phospholipase A2 group V -: Lesion distribution, activation by arterial proteoglycans, and induction in aorta by a western diet [J].

Rosengren, Birgitta ;

Peilot, Helena ;

Umaerus, Mia ;

Jonsson-Rylander, Ann-Cathrine ;

Mattsson-Hulten, Lillemor ;

Hallberg, Carina ;

Cronet, Philippe ;

Rodriguez-Lee, Mariam ;

Hurt-Camejo, Eva .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2006, 26 (07) :1579-1585

← 1 2 →